Technical Analysis for SURF - Surface Oncology, Inc.

Grade Last Price % Change Price Change
F 9.02 6.37% 0.54
SURF closed up 6.37 percent on Monday, March 1, 2021, on 57 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical SURF trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish 6.37%
Lower Bollinger Band Walk Weakness 6.37%
Wide Bands Range Expansion 6.37%
Oversold Stochastic Weakness 6.37%
180 Bearish Setup Bearish Swing Setup 6.87%
Lower Bollinger Band Walk Weakness 6.87%
Wide Bands Range Expansion 6.87%
Lower Bollinger Band Touch Weakness 6.87%
Older End-of-Day Signals for SURF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 6 hours ago
Rose Above Previous Day's High about 11 hours ago
Up 5% about 11 hours ago
Up 3% about 11 hours ago
Up 2% about 11 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Surface Oncology is a clinical-stage immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD47 and CD73. Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response, alone or in combination with other therapies. The company has a pipeline of immunotherapies and a strategic collaboration with Novartis focused on up to three next-generation cancer immunotherapies.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunotherapy Cancer Treatments Cancer Immunotherapy Virotherapy Tumor Immunotherapies Cancer Research Novel Cancer Cd73 CD47 Active Immunotherapy Tumor Microenvironment

Is SURF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.38
52 Week Low 1.38
Average Volume 1,603,268
200-Day Moving Average 7.61
50-Day Moving Average 10.57
20-Day Moving Average 10.35
10-Day Moving Average 9.34
Average True Range 0.85
ADX 26.09
+DI 15.73
-DI 31.19
Chandelier Exit (Long, 3 ATRs ) 10.15
Chandelier Exit (Short, 3 ATRs ) 10.56
Upper Bollinger Band 12.79
Lower Bollinger Band 7.92
Percent B (%b) 0.23
BandWidth 46.98
MACD Line -0.63
MACD Signal Line -0.37
MACD Histogram -0.2613
Fundamentals Value
Market Cap 366.9 Million
Num Shares 40.7 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -6.80
Price-to-Sales 6.80
Price-to-Book 3.88
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.83
Resistance 3 (R3) 9.78 9.46 9.70
Resistance 2 (R2) 9.46 9.25 9.49 9.65
Resistance 1 (R1) 9.24 9.13 9.35 9.29 9.60
Pivot Point 8.92 8.92 8.98 8.95 8.92
Support 1 (S1) 8.70 8.71 8.81 8.75 8.44
Support 2 (S2) 8.38 8.59 8.41 8.39
Support 3 (S3) 8.16 8.38 8.35
Support 4 (S4) 8.21